Sergei Chudopal

Sergei Chudopal

Auto-generated profile, based on publicly available information

Sergei Chudopal

Federal State Budgetary Educational Institution of Higher Education «Kabardino — Balkarian State University named after Kh. M. Berbekov» of the Ministry of Education and Science of the Russian Federation, 173 Chernyshevsky St., Nalchik, Kabardino — Balkarian Republic, 360004, Russian Federation

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Social Aspects of Population Health
Verified
Journal Article
Closed access
AAAzis Akhokhova
Azis Akhokhova
SESvetlana Eshtrekova
Svetlana Eshtrekova
AEAmina Eshtrekova
Amina Eshtrekova
ITIrina Tkhabisimova
Irina Tkhabisimova
AKArtur Khadzugov
Artur Khadzugov
RSRussian Federation Llc Firm Sem
Russian Federation Llc Firm Sem

30 June 2026 in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
Verified
Journal Article
Closed access
AAA. V. Akhokhova
A. V. Akhokhova
SCS. M. Chudopal
S. M. Chudopal
NBN. M. Begidova
N. M. Begidova
MMM. A. Musukova
M. A. Musukova
IAI. B. Aidamirova
I. B. Aidamirova
SSS. A. Shokuev
S. A. Shokuev
Introduction. For clinical narcology, it is important not only to record registered patients but also to identify situations in which early referral to specialized care decreases, while severe intoxications and fatalities increase. The aim of this study was to develop and apply a clinical and narcological marker model for identifying hidden toxicological risks in the Kabardino — Balkarian Republic from 2014 to 2024. Methods. A retrospective observational study was conducted using aggregated, anonymized data from federal statistical observation forms No. 11, No. 37, No. 42, form No. 30, and toxicological and forensic medical contours. The primary drug input P=P08+P16, acute toxicological contour O=B+D, monitoring divergence index IDM=O/P, lethal toxicity coefficient K=D/O x 100 %, mortality per 100,000 population and age shift of fatal outcomes were calculated. Results. With a decrease in P from 621 to 227 cases, O increased from 108 to 213 events. IDM increased from 0.174 to 0.938; the threshold of 0.50 was exceeded in 2023–2024. Mortality from drug poisoning had an upward trend (τ=0.72; p=0.002), and the age structure of fatal outcomes shifted to the 18–30 year old group (χ²=32.03; p<0.001). Conclusion. A marker model of clinical alertness is proposed that links late entry into drug treatment, increased acute toxicological risk, increased mortality, and a younger age at which severe outcomes occur. The model is designed for early inter — contour verification and patient routing. The practical significance of the model lies in the possibility of early detection of discrepancies between the registration, toxicological and lethal observation contours.

10 April 2025 in Лечащий врач
Verified
Journal Article
Closed access
ZLZ.N. Lovpache
Z.N. Lovpache
SCS.M. Chudopal
S.M. Chudopal
EUE.S. Ulimbasheva
E.S. Ulimbasheva
TAT.M. Aliev
T.M. Aliev
Background. Neuritis of the facial nerve is a rare complication of acute purulent otitis media, which, in addition to the symptoms of otitis media, is accompanied by dysfunction of facial muscles, facial asymmetry, ophthalmological disorders, etc. Opinions regarding the pathophysiologic mechanisms of the complication include anatomic variations of the facial nerve, retrograde infection, exposure of the nerve to bacterial and viral toxins, and impaired blood supply to the nerve due to thrombosis or compression of the vessels feeding it. The complication reduces the quality of life by 2-3 months, can have long-term consequences and requires timely diagnosis and treatment in conditions of consolidation of specialists of various profiles. The course and outcomes of the disease depend on the aggressiveness of the infectious agent, timely diagnosis, adequate antibacterial and other therapy, and the state of the patient's immune system. Objective. Generalization and systematization of current data on pathogenesis, clinical manifestations, diagnostic methods and treatment of facial nerve neuritis of otogenic origin; presentation of a clinical case of facial nerve lesion in an adult patient with acute purulent otitis media. Results. A comprehensive analysis of the existing theories of the pathophysiology of facial neuritis of otogenic origin; the main conservative and surgical approaches to the treatment of the disease; and the role of non-drug therapy is described. The article also presents a clinical case of facial nerve damage in an adult patient with acute purulent otitis media. Conclusion. Despite the rarity of the described complication, timely diagnosis and adequate treatment are required to achieve a favorable outcome and prevent chronic neurological consequences. Efforts to improve the quality of treatment of the underlying disease, the development of strategies for interaction between various specialists, combined with strict adherence to the treatment regimen by patients with otitis media can lead to success in the fight against facial nerve neuritis of otogenic genesis.

26 June 2026 in Medical Technologies. Assessment and Choice
Verified
Journal Article
Closed access
AAA.V. Akhokhova
A.V. Akhokhova
MTM.KH. Tlakadugova
M.KH. Tlakadugova
SCS.M. Chudopal
S.M. Chudopal
KKK.B. Kogotyzheva
K.B. Kogotyzheva
MSM.S. Sadaeva
M.S. Sadaeva
MKM.A. Kushkhova
M.A. Kushkhova
Increasing the coverage of patients with chronic cardiovascular diseases with regular medical checkups and expanding the free drug provision program remain key public policy objectives. Prototyping as a tool for adaptive optimization of centralized drug provision in federal project «The fight against cardiovascular diseases» is presented. Prototyping is interpreted as a mechanism for flexible resource management and proactive modeling of procurement planning and drug write-off processes in real time. This mitigates management risks. Under regulatory dynamics and changing clinical guidelines, this model enables prompt adjustments to procurement parameters, supply volumes and logistics decisions based on up-to-date data on patient needs. This underlies transition from retrospective control to proactive resource management. Formalizing the project using the function-process model provides a basis for iterative hypothesis testing and rapid decision adjustments. This approach creates end-to-end management data framework ensuring traceability of information flow at all stages of procurement lifecycle (from demand generation to subsidy utilization reporting). The Boehm spiral in procurement practices avoids formulaic tenders, improves alignment of stakeholder requirements and expedites regulatory updates. Prototyping should be considered a socially oriented tool for adapting innovations in management of regional healthcare projects. Spiral approach allows for phased testing of management decisions before their scaling. This reduces the likelihood of systemic errors and ensures controllable adoption of uncertainty. Spiral prototyping is reasonable for adaptive optimization of centralized drug supply for patients with cardiovascular diseases. The function-process model and Boehm spiral reduce management risks and minimize write-offs. Integration of spiral logic into the project participant interaction architecture ensures alignment of functions, processes and data creating a stable management framework capable of adapting to changing budget constraints and federal program requirements.